Levonorgestrel (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Levonorgestrel" in Turkish language version.

refsWebsite
Global rank Turkish rank
1st place
1st place
3rd place
5th place
4th place
11th place
2nd place
4th place
399th place
156th place
447th place
858th place
low place
low place
low place
low place

books.google.com

doi.org

  • "Mechanism of action of emergency contraception". Contraception. 82 (5): 404-409. November 2010. doi:10.1016/j.contraception.2010.05.004. PMID 20933113. 
  • "Clinical trials in male hormonal contraception" (PDF). Contraception. 82 (5): 457-470. November 2010. doi:10.1016/j.contraception.2010.03.020. PMID 20933120. 5 Aralık 2020 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Temmuz 2019. 
  • "A review of androgen-progestin regimens for male contraception". Journal of Andrology. 24 (4): 466-83. 2003. doi:10.1002/j.1939-4640.2003.tb02695.x. PMID 12826683. Based on animal studies and clinical studies in women, 19‐norderived progestins are known to be potent in terms of gonadotropin suppression (Couzinet et al, 1996). Among this class of steroidal compounds are norethisterone (NET), norethynodrel, and its dextrorotatory isomer LNG (ie, the biologically active form of this progestin). The progestins of this class are known to be potent suppressors of gonadotropin secretion, and when administered to men these compounds induced a profound suppression of sperm production (Frick, 1973). However, a decrease of libido and sexual potency was also reported, presumably due to the suppression of T production secondary to gonadotropin suppression (Kamischke et al, 2000b). Therefore, like other progestins available thus far, nor‐progestins should not be administered alone for male contraception because their residual androgenic activity is not sufficient to maintain androgen‐dependent physiological functions like libido or sexual potency (Kamischke et al, 2000a). 

drugs.com

fda.gov

accessdata.fda.gov

kup.at

nih.gov

ncbi.nlm.nih.gov

  • "Mechanism of action of emergency contraception". Contraception. 82 (5): 404-409. November 2010. doi:10.1016/j.contraception.2010.05.004. PMID 20933113. 
  • "Clinical trials in male hormonal contraception" (PDF). Contraception. 82 (5): 457-470. November 2010. doi:10.1016/j.contraception.2010.03.020. PMID 20933120. 5 Aralık 2020 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Temmuz 2019. 
  • "A review of androgen-progestin regimens for male contraception". Journal of Andrology. 24 (4): 466-83. 2003. doi:10.1002/j.1939-4640.2003.tb02695.x. PMID 12826683. Based on animal studies and clinical studies in women, 19‐norderived progestins are known to be potent in terms of gonadotropin suppression (Couzinet et al, 1996). Among this class of steroidal compounds are norethisterone (NET), norethynodrel, and its dextrorotatory isomer LNG (ie, the biologically active form of this progestin). The progestins of this class are known to be potent suppressors of gonadotropin secretion, and when administered to men these compounds induced a profound suppression of sperm production (Frick, 1973). However, a decrease of libido and sexual potency was also reported, presumably due to the suppression of T production secondary to gonadotropin suppression (Kamischke et al, 2000b). Therefore, like other progestins available thus far, nor‐progestins should not be administered alone for male contraception because their residual androgenic activity is not sufficient to maintain androgen‐dependent physiological functions like libido or sexual potency (Kamischke et al, 2000a). 

dailymed.nlm.nih.gov

  • "Plan B One-Step- levonorgestrel tablet" 26 Aralık 2022 tarihinde Wayback Machine sitesinde arşivlendi..

reliasmedia.com

web.archive.org

  • "Plan B One-Step- levonorgestrel tablet" 26 Aralık 2022 tarihinde Wayback Machine sitesinde arşivlendi..
  • "Progestins (Etonogestrel, Levonorgestrel, Norethindrone)". The American Society of Health-System Pharmacists. 7 Eylül 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Ağustos 2015. 
  • Postgraduate Gynecology. Jaypee Brothers Medical Pub. 2011. s. 159. ISBN 9789350250822. 26 Eylül 2015 tarihinde kaynağından arşivlendi. 
  • "Levonorgestrel 1.5 mg Tablet Emergency Contraceptive: New Drug Application 21998, Supplement 5" (PDF). U.S. Food and Drug Administration. 15 Mayıs 2023 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 25 Haziran 2023. 
  • "Now Is the Time to Change Label on Emergency Contraceptives". Relias Media | Online Continuing Medical Education | Relias Media - Continuing Medical Education Publishing (İngilizce). 24 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ağustos 2022. 
  • "Chapter 1". Research on reproductive health at WHO : biennial report 2000-2001. Cenevre: World health organization. 2002. ISBN 9789241562089. 26 Eylül 2015 tarihinde kaynağından arşivlendi. 
  • Analogue-based Drug Discovery. John Wiley & Sons. 2006. s. 479. ISBN 9783527607495. 28 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Ağustos 2020. 
  • Chemische Leckerbissen. John Wiley & Sons. 2014. ss. 77-. ISBN 978-3-527-33739-2. 28 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2018. [Levonorgestrel (24): The product generated by Smith's norgestrel total synthesis was a racemate, so half of each consisted of the left- and the right-handed enantiomer. Chemists at Schering discovered that only the levorotatory enantiomer was effective [49] and developed a biotechnological process for the preparation of the pure levorotatory enantiomer. This was the active ingredient levonorgestrel born. With the single-acting enantiomer, the dose and thus the liver burden could be halved again. The resulting Neogynon® contained 0.25 mg levonorgestrel and 0.05 mg ethinylestradiol and was introduced in 1970.] 
  • Tarascon pocket pharmacopoeia : 2014 deluxe lab-pocket edition. 15th. Sudbury: Jones & Bartlett Learning. 2014. ss. 310-312. ISBN 9781284053999. 26 Eylül 2015 tarihinde kaynağından arşivlendi. 
  • "Clinical trials in male hormonal contraception" (PDF). Contraception. 82 (5): 457-470. November 2010. doi:10.1016/j.contraception.2010.03.020. PMID 20933120. 5 Aralık 2020 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Temmuz 2019.